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Summary
Background Past research in population health trends has shown 
that injuries form a substantial burden of population health loss. 
Regular updates to injury burden assessments are critical. We report 
Global Burden of Disease (GBD) 2017 Study estimates on morbidity 
and mortality for all injuries.
methods We reviewed results for injuries from the GBD 2017 study. 
GBD 2017 measured injury- specific mortality and years of life lost 
(YLLs) using the Cause of Death Ensemble model. To measure non- fatal 
injuries, GBD 2017 modelled injury- specific incidence and converted 
this to prevalence and years lived with disability (YLDs). YLLs and YLDs 
were summed to calculate disability- adjusted life years (DALYs).
Findings In 1990, there were 4 260 493 (4 085 700 to 4 396 138) 
injury deaths, which increased to 4 484 722 (4 332 010 to 4 585 554) 
deaths in 2017, while age- standardised mortality decreased from 1079 
(1073 to 1086) to 738 (730 to 745) per 100 000. In 1990, there were 
354 064 302 (95% uncertainty interval: 338 174 876 to 371 610 802) 
new cases of injury globally, which increased to 520 710 288 (493 
430 247 to 547 988 635) new cases in 2017. During this time, age- 
standardised incidence decreased non- significantly from 6824 (6534 to 
7147) to 6763 (6412 to 7118) per 100 000. Between 1990 and 2017, 
age- standardised DALYs decreased from 4947 (4655 to 5233) per 
100 000 to 3267 (3058 to 3505).
Interpretation Injuries are an important cause of health loss 
globally, though mortality has declined between 1990 and 2017. 
Future research in injury burden should focus on prevention in high- 
burden populations, improving data collection and ensuring access to 
medical care.
InTrOduCTIOn
Injury burden assessments are a critical component of popula-
tion health measurement. Across the global landscape of popu-
lation health research, injuries are unique in that they are almost 
universally avertable yet can cause death or disability at any age. 
Even common injuries such as concussion resulting from falls, 
violence or road injuries may cause longer term sequelae, and 
injuries such as spinal cord injuries or limb amputations can cause 
long- term disability.1 As a result, injuries are recognised as being 
a source of lost health and human capital that could be averted 
with improved safety and prevention programmes as well as 
ensuring access to care resources.2 Across geographies, certain 
injuries such as envenomation may be relevant in specific loca-
tions where venomous creatures live, while injuries such as those 
occurring from adverse medical events are an increasing area 
of research in higher income areas of the world.3–5 Bolstering 
such programmes, however, requires detailed measurement of 
when, where and to whom injuries are occurring, necessitating 
focused research studies to add insight and context to broader 
geographical trends. Across all domains of injury prevention 
research, it is important to measure the causes of injury, such as 
road injuries, and the resulting disability, such as fractures, burns 
or traumatic brain injury, that can occur as a result. Such detailed 
measurement lends perspective for understanding burden and 
anticipating resources needed to care for and hopefully prevent 
future injury burden. Detailed measurements and assessments of 
this nature are critical for empowering policy makers and health 
system planners to appropriately plan and invest for mitigating 
future health loss from injuries. Reducing injury burden is an 
important component in global efforts such as the Sustainable 
Development Goal 3 to ‘ensure healthy lives and promote well- 
being for all at all ages’.6
While some research has focused on a certain type of injury 
or outcome from injury or specific area of the world,7–10 it 
has become important in an era of more sophisticated popula-
tion health measurement to measure health loss from injuries 
comprehensively with detailed fatal and non- fatal estimates 
for different ages, sexes, across time periods and accounting 
for multiple different types of morbidity that can occur in an 
injury. Previously published literature on global injury burden 
through 2015 has provided comprehensive measurements of 
health loss due to injuries but still require regular updates to 
help inform research and policy, as new years of estimates are 
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added and as new injuries and injury outcomes are incorpo-
rated.11 Comprehensive research of this nature shows how 
injury burden varies dynamically by age, sex, year, area of the 
world and type of injury, and hence, it is important to main-
tain close monitoring of injury burden every year in all parts of 
the world. In addition, as new datasets and statistical model-
ling methods become available, producing regular updates to 
burden estimation also ensures that results are as accurate as 
possible.
While the burden of injuries is widely studied and moni-
tored through various methods of research, the Global Burden 
of Diseases, Injuries, and Risk Factors (GBD) Study is the only 
study framework that routinely provides estimates of morbidity 
and mortality from an exhaustive list of injuries in all areas of 
the world across ages and sexes. The most recent update to GBD 
was published in 2018 and provided morbidity and mortality 
estimates for 30 mutually exclusive causes of injury for 195 
countries from 1990 to 2017.12–17 As part of this regular update, 
new datasets on cause of death and incidence are incorporated 
into the study, and additional geographical detail is added to 
better measure heterogeneity in burden estimates at a subna-
tional level. In addition, updates such as reporting both nature 
of injury and cause of injury (described in more detail below) are 
incorporated. In this study, we describe key components in the 
GBD injury methodology and provide results from key trends 
in injury burden in terms of incidence, prevalence, years lived 
with disability (YLDs), cause- specific mortality, years of life lost 
(YLLs) and disability- adjusted life years (DALYs) by country, age 
groups, sex, year and injury type.
meThOdS
The methods and results in this study are the same as are 
provided in GBD capstone publications, and a detailed descrip-
tion of GBD data and methods used for all processes related 
to GBD 2017 is provided in associated studies.12–17 Overall, 
GBD methods are also summarised in online supplementary 
appendix 1. Below, we summarise the specific methods used 
for measurement of injuries morbidity and mortality in GBD 
2017.
Key components of GBd study design
The GBD study incorporates several key components to allow 
for internally consistent estimates across all burden measures 
and metrics. First, population is measured to ensure consistent 
denominators for all population- level measurement. Second, all- 
cause mortality is measured using demographic methods. Third, 
cause- specific mortality for a mutually exclusive, collectively 
exhaustive hierarchy of diseases and injuries is measured, such 
that every death has one underlying cause of death and such that 
estimates for every possible cause of death are included, which 
requires the use of residual causes like ‘other transport injuries’. 
This results in the sum of cause- specific mortality equalling total 
all- cause mortality. Fourth, non- fatal health loss is measured for 
individuals living with a disease or injury that detracts from their 
full health status. Fifth, a composite measure of mortality and 
morbidity is computed. These steps are conducted within an age, 
sex and location hierarchy constructed such that demographic 
detail is available but where all estimates are internally consistent 
with all other estimates. GBD produces estimates for all causes, 
ages, sexes, years and locations. Risk factors and attributable 
burden for different are also measured, but those results are not 
included in this study.
Case definition and cause hierarchy
The GBD case definition for an injury death is a death where the 
injury was the underlying cause of death. For example, if an indi-
vidual falls on ice and sustains an epidural haematoma and dies 
after a seizure, the fall is the underlying cause. If an individual 
sustains a myocardial infarction and then falls and sustains the 
same epidural haematoma, then the myocardial infarction is the 
underlying cause of death. For non- fatal injuries, we define a 
case as an injury that warranted medical care. For example, if an 
individual slips and falls but does not sustain any bodily injury, 
it is not considered an injury. Online supplementary appendix 
table 1 provides the International Classification of Disease (ICD) 
codes used to identify causes of injury.
Cause-specific mortality estimation
Cause- specific mortality from injuries is measured using the 
Cause of Death Ensemble model (CODEm). CODEm is described 
in more detail elsewhere; a summary of its use for injuries is as 
follows.18 First, all available data that can be used for cause of 
death estimation are identified. For injuries, this includes vital 
registration, verbal autopsy, police records, mortuary data and 
census data. These data are processed for use in the GBD cause 
and demographic hierarchy via a series of data processing steps 
including a process whereby ill- defined causes of death are reas-
signed to true underlying causes of death, which is described in 
more detail elsewhere but essentially is the process by which ill- 
defined causes of death are reclassified to causes of death in the 
GBD cause hierarchy.19 20 Next, a cause- specific mortality model 
is developed for each one of the 30 different causes of injury. For 
example, falls are modelled differently than road injuries, though 
both use the same CODEm modelling architecture. For each 
cause of injury, covariates that may be associated with the cause 
are identified and added as candidate covariates. CODEm runs 
different combinations of models using different covariates and 
outcome variables, specifically cause fraction models and cause- 
specific mortality rate models. Ensembles of models are also 
conducted to test performance of overall models formed from 
submodels. Once all models have been run, the top- performing 
models are selected based on out- of- sample predictive validity, 
wherein the model makes predictions on data that were not 
included in developing the model. The top- performing models 
are then weighted according to performance, and the final esti-
mates form the penultimate estimate for cause- specific mortality 
from that injury. Those estimates are then adjusted to fit within 
the all- cause mortality estimate, so that cause- specific deaths 
sum up to the overall mortality estimate for each population and 
demographic. YLLs are computed as the cause- specific mortality 
rate at a given age multiplied by the residual life expectancy at 
that age, which is based on the observed maximum global life 
expectancy.
non-fatal injury estimation
Non- fatal injury estimation is also described in more detail in 
GBD literature. Key components in this process are as follows. 
First, data on incidence of non- fatal injury causes (eg, road inju-
ries) is obtained from the GBD collaborator network and other 
injury research groups and researchers around the world. Data are 
cleaned and organised according to GBD study guidelines. Next, 
incidence of each cause of injury is modelled in DisMod- MR 
2.1, which is a Bayesian meta- analysis tool used extensively in 
GBD research. Incidence estimates of injuries requiring medical 
care for each cause of injury then stream through an analyt-
ical pipeline. During this process, injury incidence is split into 
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inpatient and outpatient to account for the different severity that 
is expected to occur. The coefficient that determines this split 
is derived from locations where both inpatient and outpatient 
data are available. After this, we measure the proportion of each 
cause of injury that leads to one of 47 different natures of injury 
using clinical data where both cause and nature are coded as well 
a Dirichlet statistical modelling process. Based on these steps, 
the incidence of each cause is also split into incidence of each 
cause- nature, which is the proportion of a given cause’s inci-
dence leading to some specific nature of injury being the most 
severe injury sustained as estimated by the Dirichlet regression. 
These estimates are then converted to short- term and long- term 
injuries based on probability of each injury becoming long term, 
as determined by long- term follow- up injury surveys.21–27 For 
short- term injuries, incidence is converted to prevalence based 
on multiplying incidence by an expected duration of injury as 
determined by physicians and injury experts involved in the 
GBD study. For long- term injuries, incidence is converted to 
prevalence using differential equations that take into account the 
increased mortality for certain types of injury, for example, trau-
matic brain injury.1 Disability weights as derived elsewhere in the 
GBD study are then used to measure disability based on nature 
of injury.28 These measures are then summed across natures of 
injury for each cause to calculate YLDs. Each of these steps is 
conducted for every cause, age, sex, year and location in the 
GBD study design. Associated literature provides more detail on 
each of these steps.12–17
daLy measurement
DALYs are calculated by summing YLLs and YLDs for each 
cause, age, sex, year and location.
uncertainty measurement
Uncertainty is measured at each step of the analytical process 
based on the sample size, SE or original uncertainty interval (UI) 
from each input to the study. Uncertainty is propagated through 
each step of the analysis by maintaining distributions of 1000 
draws on which each analytical step is conducted. Final 95% 
UIs are determined based on the 25th and 975th values of the 
ordered values across draws.
Code and results
Steps of the analytical process were conducted in Python version 
2.7, Stata V.13.1 or R version 3.3. All steps of the analytical 
process are available online at  ghdx. healthdata. org. This study 
reports a subset of measures and metrics for every cause of 
injury. All results and results with additional detail by age, sex, 
year and location can be downloaded at  ghdx. healthdata. org.
Guidelines for accurate and Transparent health estimates 
reporting (GaTher) statement
This study is adherent with guidelines from the GATHER 
(described in more detail in online supplementary appendix 2).29
reSuLTS
Online supplementary appendix table 2 shows age- standardised 
incidence, prevalence, YLDs, deaths, YLLs and DALYs in 2017 
by country as well as percentage change and UI from 1990 for 
each metric. Online supplementary appendix table 3 shows all- 
age numbers (ie, not divided by population) of incidence, prev-
alence, YLDs, deaths, YLLs and DALYs in 2017 by country as 
well as percentage change from 1990 and UI for each metric. 
In some instances, the UI for the per cent change crosses zero, 
meaning that statistically there was no significant difference. 
Online supplementary appendix figures 1–6, show the incidence 
and mortality from transport injuries, unintentional injuries, 
and interpersonal violence and self- harm by country for 2017 as 
well as the percentage change for both incidence and mortality 
between 1990 and 2017. All other results including age- specific 
and sex- specific results can be viewed and downloaded via freely 
and publicly available tools at  ghdx. healthdata. org.
Global trends in overall injury burden
In terms of fatal outcomes, deaths due to all injuries increased from 
4 260 493 (4 085 700 to 4 396 138) in 1990 to 4 484 722 (4 332 
010 to 4 585 554) in 2017, while YLLs decreased from 232 104 
206 (219 920 058 to 241 973 733) to 195 231 148 (188 807 653 
to 199 825 464) and age- standardised mortality rates decreased 
from 1079 (1073 to 1086) to 738 (730 to 745) per 100 000. 
In terms of non- fatal outcomes, all- injury incidence (new cases) 
increased from 354 064 302 (338 174 876 to 371 610 802) in 
1990 to 520 710 288 (493 430 247 to 547 988 635) in 2017, and 
YLDs increased from 37 452 031 (27 805 854 to 49 010 103) to 
57 174 469 (42 073 855 to 75 427 036), while age- standardised 
incidence rates decreased non- significantly from 6824 (6534 to 
7147) to 6763 (6412 to 7118) per 100 000. In terms of DALYs, 
age- standardised DALY rates decreased from 4947 (4655 to 5233) 
per 100 000 in 1990 to 3267 (3058 to 3505) in 2017.
Figure 1 shows age- standardised DALY rates by country for 
2017. While certain countries—specifically, Syria, Central African 
Republic and Iraq—have much higher DALY rates than most 
other countries, there still exists considerable heterogeneity across 
countries that are not among these countries with the highest 
burden. South Sudan, Somalia and Yemen have much higher injury 
burden than much of the rest of the world, for example, with age- 
standardised DALY rates of 7391.51 per 100 000 (6536.44 to 
8440.14), 7364.66 per 100 000 (6143.11 to 8960.58) and 7297.88 
per 100 000 (6525.7 to 8438.15), respectively. Papua New Guinea 
also demonstrates high all- injury burden with 6803.33 DALYs per 
100 000 (5652.2 to 8040.89) in 2017.
Figure 2 presents deaths as a stacked graph for overall injury 
groups and population from 1990 to 2017 with labelled fatal 
discontinuities, defined as changes in deaths due to sudden, 
unexpected spikes in mortality that depart from the underlying 
mortality trend.13 Although population has steadily increased in 
the 28 years of the study, deaths per year due to injuries have 
remained relatively consistent over time. Natural disasters, such 
as earthquakes, have caused pronounced spikes in unintentional 
injuries deaths, while conflict and genocide have caused spikes in 
deaths in the interpersonal violence injury category.
all-injury yLds and yLLs by country in 2017
Figure 3 shows the percentage of total all- age, combined- sex 
YLDs by country in 2017. This figure shows several geographical 
patterns that help depict the non- fatal burden of injuries glob-
ally in terms of their relative contribution to overall disability. 
First, the percentage of total disability caused by injuries varies 
widely by country. Mauritius experiences only 3.04% (2.79% to 
3.29%) of non- fatal burden from injuries, while Slovenia expe-
riences 19.11% (17.11% to 21.27%) of non- fatal burden from 
injuries. In other words, if all disability in these two popula-
tions is combined in 2017, there is over sixfold variation in how 
much of this disability was caused by injuries. These patterns 
also reflect burden from non- injury conditions, since locations 
with higher burden from communicable disease may have corre-
spondingly lower proportion due to injuries. As an extension of 
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Figure 1 Age- standardised DALY rates by country, 2017. DALYs, disability- adjusted life years.
Figure 2 Global deaths for level 2 injuries and population from 1990 to 2017 with labelled fatal discontinuities.
these geographical trends, this map makes it evident that there 
are striking regional patterns in non- fatal injury burden. Eastern 
and Central Europe and Central Asia as well as Australasia have 
a notably higher percentage of total non- fatal burden from inju-
ries than countries in other regions, while these percentages are 
relatively lower in most areas of Africa, the Americas and areas 
of South, East and Southeast Asia. To some extent, this map also 
reflects the underlying burden from non- injury causes, too, since 
areas of the world with high non- fatal disability from conditions 
such as anaemia, communicable diseases and other types of health 
loss could have correspondingly higher percentages of disability 
from these conditions instead of injuries. This map also shows 
examples of positive deviations from global trends; Indonesia, 
for example, has a relatively low percentage of non- fatal health 
loss due to injuries compared with many other countries.
Figure 4 similarly shows the percentage of total all- age, 
combined- sex YLLs by country in 2017. This figure inter-
estingly shows how mortality patterns demonstrate different 
geographical trends than the non- fatal burden, as depicted 
in figure 2, though it should be noted that YLLs will also be 
disproportionately higher in younger populations, all else being 
equal. In particular, the locations with the highest percentage 
of YLLs due to injuries are in certain countries in North Africa 
and the Middle East, including Syria, where 59.51% (56.59% 
to 62.35%) of YLLs were due to injuries in 2017, and Iraq, 
where 41.34% of YLLs were due to injuries in 2017. Areas of 
 o
n
 July 22, 2020 by guest. Protected by copyright.
http://injuryprevention.bmj.com/
Inj Prev: first published as 10.1136/injuryprev-2019-043494 on 24 April 2020. Downloaded from 
James SL, et al. Inj Prev 2020;0:1–19. doi:10.1136/injuryprev-2019-0434948
Original research
Figure 3 Percentage of YLDs in all ages due to injuries in 2017. YLDs, years lived with disability.
Figure 4 Percentage of YLLs in all ages due to injuries in 2017. YLLs, years of life lost.
Latin America including Venezuela, Honduras and Belize also 
have a relatively high percentage of total YLLs due to injuries. 
Conversely, certain areas of the world also demonstrate a rela-
tively low percentage of total YLLs due to injuries, specifically, 
certain countries in Africa such as Nigeria and Madagascar 
have relatively lower percentages, though this also reflects rela-
tively higher mortality from other non- injury causes in these 
countries.
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Figure 5 Age- standardised DALY rates by sex for injuries in level 3 of the GBD cause hierarchy in 2017 and percentage change from 1990 to 2017. 
DALY, disability- adjusted life year; GBD, Global Burden of Disease.
Cause-specific daLy rates by sex
Figure 5 shows cause- specific DALY rates by sex for 17 injuries in 
2017 as well as percentage change from 1990 to 2017 by cause and 
sex. The black and dark blue bars show causes with greater relative 
improvement over the time period of this study, while lighter blue, 
orange and red show injuries that have had lesser improvements, 
no improvements or increasing burden over time.
In 2017, men experienced higher age- standardised DALY rates 
than women for all injuries except fire, heat and hot substances. 
The most marked differences, where DALY rates for men are 
more than double those of women, can be seen in self- harm, 
interpersonal violence, road injuries, other transport inju-
ries, exposure to mechanical forces, environmental heat and 
cold exposure, and executions and police violence. Road inju-
ries (1272 (1209 to 1331) per 100 000), self- harm (577 (525 
to 604)) and falls (550 (462 to 653)) were the causes with the 
highest DALY rates for men in 2017. Women had the highest 
DALY rates due to the same injuries, but at a lesser magnitude, 
with rates of 467 (432 to 502) per 100 000 for road injuries, 367 
(304 to 442) for falls and 282 (268 to 293) for self- harm.
The causes with the largest decreases in DALY rates for men 
from 1990 to 2017 were exposure to forces of nature (72.4% 
(63.8% to 79.1%)), drowning (62.7% (58.8% to 65.4%)) and 
fire, heat and hot substances (43.6% (26.4% to 49.9%)). For 
women, exposure to forces of nature (72.8% (63.8% to 79.6%)), 
drowning (65.8% (58.6% to 69.2%)) and self- harm (50.8% 
(48.2% to 55.9%)) had the largest decreases in DALY rates. The 
only increases in DALY rates were seen in executions and police 
conflict for both women (298.0% (257.1% to 389.0%)) and 
men (46.4% (31.2% to 173.0%)).
Comparative regional daLy rates in 2017
Figure 6 shows a heatmap of the number of standard devia-
tions (SD) above or below the mean of a row (ie, a Z- score) of 
age- standardised DALY rates for select injuries by GBD region 
in 2017. For example, the figure shows that the rate of age- 
standardised DALYs in Eastern Europe is approximately three 
SD higher than the across mean age- standardised DALY rates 
of environmental heat and cold exposure across all regions. 
Poisonings is also a cause with an age- standardised DALY rate 
that is approximately three SD higher than in other regions. 
Positive deviance is seen in high- income Asia Pacific for road 
injuries, where age- standardised DALYs are one SD lower than 
the mean across regions. Conversely, Central sub- Saharan Africa 
has age- standardised DALY rates that are two SD higher than the 
mean across regions. This figure also demonstrates how certain 
causes have relatively less variation across regions, for example, 
most regions do not deviate from the mean age- standardised 
DALY rates across regions for exposure to forces of nature, with 
the exception of the Caribbean, which had an age- standardised 
DALY rate that was approximately four SD above the mean 
across regions in 2017. Oceania and Eastern Europe stand out as 
having higher DALY rates for select injuries than other regions, 
while East Asia, high- income Asia Pacific, high- income North 
America, Western Europe and Southern Latin America experi-
enced less than average burden of injuries in 2017.
dISCuSSIOn
Measuring, understanding and acting on the global burden of 
injuries should be considered a foundational component of 
population health research. While this study has reviewed injury 
burden trends from GBD 2017, it is also evident that these 
trends are sufficiently different by injury type and geography 
that it becomes difficult to succinctly generalise the findings in 
this study. Nevertheless, this study reveals themes and principles 
germane to the state of global injury burden in 2017 that are 
relevant to injury burden and prevention research.
First, it should be recognised that despite global popula-
tion growth with increases in injury cases and deaths, age- 
standardised death rates from injuries declined from 1990 to 
2017. More research into successful improvements for specific 
injuries in specific countries should be more investigated to help 
guide efforts towards future improvements. In general terms, 
the reduction in injury mortality likely represent the combined 
effects of improvements in healthcare systems, investments in 
injury prevention programmes and, in certain circumstances, 
safety improvement such as vehicle safety testing, helmet, seatbelt 
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Figure 6 Heatmap showing the Z- score of age- standardised mean DALY rates for select injuries by GBD region in 2017. GBD, Global Burden of 
Disease.
What is already known on the subject
 ► Injury burden globally varies across many dimensions but 
remains as an important component of global health loss. 
Regular updates in injury burden measurement are critical.
 ► Injuries can be largely preventable, but prevention efforts 
must be guided by up- to- date estimates of injury burden that 
can be used on an age- specific, sex- specific, year- specific, 
location- specific and injury- specific basis.
What this study adds
 ► This study incorporates updated data and methods that were 
used in Global Burden of Disease 2017 with updated burden 
estimates for the year 2017, as well as newly available 
results in terms of nature of injury.
 ► Global age- standardised mortality and disability- adjusted life 
years decreased between 1990 and 2017. Decreases in age- 
standardised incidence were not statistically significant.
 ► Trends over time vary depending on the specific injury, sex 
and location.
 ► Injury burden in a population can be radically affected by 
war, civil conflict and natural disasters.
and drinking and driving laws. While burden trends across all 
diseases and injuries vary by geography and time, these improve-
ments in injury burden are generally consistent with reporting of 
communicable and non- communicable disease trends reported 
in GBD 2017.
Despite improvements in terms of rates, however, it is 
important to consider the impact of absolute injury burden in 
younger and adult ages on the social capital and workforce in 
a country. Second, in reviewing temporal trends in figure 2, it 
becomes evident that war and conflict and environmental disas-
ters can cause profound increases in deaths over a short period 
of time. This unfortunate and tragic reality should be made more 
broadly visible as issues such as war, conflict and climate change 
continue to threaten the populations of the 21st century. Third, 
sex differentials in the burden of different injury types are large, 
with men experiencing significantly higher burden from the four 
leading causes of injury DALYs in 2017. Preventive research and 
focused interventions into why this is occurring in road inju-
ries, falls, self- harm, interpersonal violence and drowning is 
critical. It is also critical to address injuries such as fire, heat 
and hot substance and sexual violence where females experience 
greater burden and to better understand the factors that drive 
sex differences. As a fourth theme, we observed that there are 
cases of both positive and negative deviance from cross- region 
trends for each injury, as shown in figure 6, which appear to 
occur even outside of expected differences by income group. 
For example, understanding why high- income Asia Pacific and 
Western Europe are performing better than high- income North 
America in road injury burden could help improve road injury 
burden even in this higher income setting.
Beyond these four themes, there are evidently a great deal 
of nuances and specific outcomes to measure and understand 
in future injury research. While every cause of health loss in a 
population is important to measure and understand, injuries are 
unique in that understanding burden requires investigation of 
an array of circumstances such as infrastructure, the built envi-
ronment, rates of interpersonal violence in a population and 
individual behaviours such as alcohol intoxication or drug use. 
The findings in this paper also demonstrate how it is critical 
to measure and understand the spectrum of health loss due to 
injuries ranging from relatively silent injuries to injuries that 
profoundly affect functional status. An incident as elemental as a 
trip and fall can lead to profoundly disabling health consequences 
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such as spinal cord injury, which can have lifelong disability. The 
disability caused by shorter term injuries, such as an arm frac-
ture, in addition to causing suffering and disability, can cause 
loss of human capital.30 While this study focused more on the 
causes of injury as defined in the GBD cause hierarchy, future 
GBD studies should focus also on depicting the distribution of 
nature of injury results to better understand how these types of 
disability affect an individual’s functional status. Such analyses 
become increasingly meaningful as research emerges on, for 
example, the increased risk of dementia that traumatic brain 
injury patients may experience.31 The findings in this paper also 
demonstrate how measuring injury burden necessitates review 
of the population factors that affect injury risk. For example, an 
event as disastrous as an earthquake may have radically different 
impacts on a population depending on infrastructure and access 
to care resources. Understanding how populations can protect 
themselves against future, unanticipated catastrophe could lead 
to averted death and disability in the future. As was shown in 
figure 2, catastrophic events both in terms of natural disasters 
and war and conflict can significantly add to the death and 
disability experienced by a population in a short period of time.
The geographical trends shown in this paper are also critical to 
review and understand by the broader global health community. 
As shown in figure 6, considerable heterogeneity exists across 
regions for certain causes. While vehicles were driven in nearly 
every populated area of earth in 2017, this study shows that 
different regions of the world have markedly different rates of 
death and disability resulting from road injuries, underscoring 
the importance of measuring and understanding the effects of 
specific factors on injury burden.32 It is not necessarily surprising 
to observe that countries or regions with relatively lower health-
care access and quality, less road safety infrastructure and lower 
utilisation of vehicles with modern safety standards would 
have higher rates of road injuries DALYs. The question that 
extends from this observation, however, is the extent to which 
burden from this type of injury cause could be avoided were 
every country to have the safety and prevention factors avail-
able in higher income settings. The injury and safety research 
communities should consider future investigation of counter-
factual analyses to better measure and understand the impact 
that road safety legislation, modernisation of roads and vehicles 
and improving first response medical care could have on road 
injury burden, as an example, though parallel examples can be 
developed for other injury causes as well. This research could 
help cost- effectiveness analyses and guide investment in safer 
infrastructure.
These observations converge on a common theme: much of 
the injury burden may be largely preventable and understanding 
the success or failure of different prevention efforts should be 
a prioritised area of health research. Moreover, it is critical for 
there to be continued engagement across different areas of the 
world for the purposes of discussing effective and ineffective 
injury prevention strategies. Dialogue focused on findings across 
injury prevention efforts via forums such as global safety confer-
ences as well as studies published in research journals should 
continue to help policy makers and public health planners make 
strategic investments for preventing future injury burden.33 In 
addition, more research into the cause of injury and resulting 
bodily injury and environmental and contextual features where 
injuries occur such type of road in a road injury or fires in 
factories versus in residences may provide further insight into 
preventing future injury burden.
Known limitations of injury burden estimation in the GBD 
framework have been reported previously in peer- reviewed 
literature.1 11 13 16 Generally, identified limitations include data 
sparsity and correspondingly greater uncertainty in certain geog-
raphies, limited geographical coverage of data informing long- 
term disability estimates and cause–nature relationships, and 
potential reporting biases for injuries such as self- harm and inter-
personal violence. These limitations have been discussed in the 
aforementioned literature, and this overview study was addition-
ally limited in scope due to the extensive size of the GBD cause 
hierarchy and location hierarchy. Indeed, over 1400 different 
cause–nature combinations are available for reporting in the 
GBD cause hierarchy, and future research would benefit from 
examining results in the detailed cause hierarchy and across the 
detailed location, age and sex hierarchy. The GBD Study plat-
form and collaborator network provide a constructive collabo-
rative platform on which future assessments can be conducted 
and published.
COnCLuSIOn
Injury burden is complex but foundational in formulating global 
health loss. We have identified four broad trends in global injury 
burden that converge on the principle that injuries should be 
considered largely preventable but that detailed burden estimates 
through recent years are a critical global resource to inform 
meaningful policy. It will be important accurate measurement to 
continue into the future to guide injury prevention policy.
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